SCHEMBL5312181

SCHEMBL5312181

NNc1ccc2c(=O)[nH]cc(Cl)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ PRMT5 O14744 1/20 0.36
▸ WDR77 Q9BQA1 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ BRD4 O60885 1/20 0.32
▸ ROCK2 O75116 2/20 0.32
▸ NAMPT P43490 1/20 0.32
▸ ADRA1A P35348 1/20 0.31
▸ DAO P14920 1/20 0.31
▸ AR P10275 1/20 0.31
▸ AKR1C3 P42330 1/20 0.31
▸ AURKA O14965 1/20 0.30
▸ AURKB Q96GD4 1/20 0.30
▸ SERPINE1 P05121 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31426340 0.77 PARP1 (0.46) KDM4ENPC1MAPTRAB9ATDP1
SCHEMBL3277310 0.74 HSD17B10 (0.46) KDM4ENPC1POLBMAPTRAB9A
SCHEMBL2170877 0.74 CHEK1 (0.46) ALDH1A1PARP1AURKAAURKB
SCHEMBL24172971 0.73 HTR1D (0.38) NPC1RAB9AALDH1A1PARP1
SCHEMBL31426412 0.72 CA12 (0.49) ALDH1A1ROCK2AURKB
SCHEMBL24172897 0.71 MCL1 (0.41) KDM4EAURKAAURKB
SCHEMBL3305650 0.70 PARP1 (0.49) NPC1MAPTRAB9ATDP1ALDH1A1
SCHEMBL29914866 0.70 PARP1 (0.55) KDM4ERAB9ATDP1ALDH1A1PARP1
SCHEMBL1536513 0.70 PARP1 (0.55) KDM4ERAB9ATDP1ALDH1A1PARP1
SCHEMBL1536491 0.70 PARP15 (0.47) KDM4ENPC1POLBMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007053352-A2 PYRROLOQUINOLINONE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2007-05-10 — — WO disclosed
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2007-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands HTR6, HTR5A, HTR2C KDM4E 3529/4885NPC1 1446/4885POLB 4251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback